YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

C N Rathcke; J S Johansen; H Vestergaard

doi:10.1007/s00011-005-0010-8

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

C N Rathcke, J S Johansen, H Vestergaard

139 Citations (Scopus)

Abstract

YKL-40 participates in inflammatory states and vascular processes, which implies that comparison can be made with other inflammatory markers associated with insulin resistance and type 2 diabetes (T2D). In the present study levels of plasma YKL-40 and serum hsCRP were evaluated in patients with T2D.

Original language	English
Journal	Inflammation Research
Volume	55
Issue number	2
Pages (from-to)	53-9
Number of pages	7
ISSN	1023-3830
DOIs	https://doi.org/10.1007/s00011-005-0010-8
Publication status	Published - Feb 2006

Keywords

Adipokines
Adult
Aged
Biological Markers
C-Reactive Protein
Diabetes Mellitus, Type 2
Female
Glycoproteins
Humans
Inflammation
Insulin Resistance
Lectins
Male
Middle Aged
Random Allocation
Statistics as Topic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00011-005-0010-8

Cite this

@article{ce1ad2b4cf014e848996692e9ef79b34,

title = "YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance",

abstract = "YKL-40 participates in inflammatory states and vascular processes, which implies that comparison can be made with other inflammatory markers associated with insulin resistance and type 2 diabetes (T2D). In the present study levels of plasma YKL-40 and serum hsCRP were evaluated in patients with T2D.",

keywords = "Adipokines, Adult, Aged, Biological Markers, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Glycoproteins, Humans, Inflammation, Insulin Resistance, Lectins, Male, Middle Aged, Random Allocation, Statistics as Topic",

author = "Rathcke, {C N} and Johansen, {J S} and H Vestergaard",

year = "2006",

month = feb,

doi = "10.1007/s00011-005-0010-8",

language = "English",

volume = "55",

pages = "53--9",

journal = "Inflammation Research",

issn = "1023-3830",

publisher = "Springer Basel AG",

number = "2",

}

TY - JOUR

T1 - YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

AU - Rathcke, C N

AU - Johansen, J S

AU - Vestergaard, H

PY - 2006/2

Y1 - 2006/2

N2 - YKL-40 participates in inflammatory states and vascular processes, which implies that comparison can be made with other inflammatory markers associated with insulin resistance and type 2 diabetes (T2D). In the present study levels of plasma YKL-40 and serum hsCRP were evaluated in patients with T2D.

AB - YKL-40 participates in inflammatory states and vascular processes, which implies that comparison can be made with other inflammatory markers associated with insulin resistance and type 2 diabetes (T2D). In the present study levels of plasma YKL-40 and serum hsCRP were evaluated in patients with T2D.

KW - Adipokines

KW - Adult

KW - Aged

KW - Biological Markers

KW - C-Reactive Protein

KW - Diabetes Mellitus, Type 2

KW - Female

KW - Glycoproteins

KW - Humans

KW - Inflammation

KW - Insulin Resistance

KW - Lectins

KW - Male

KW - Middle Aged

KW - Random Allocation

KW - Statistics as Topic

U2 - 10.1007/s00011-005-0010-8

DO - 10.1007/s00011-005-0010-8

M3 - Journal article

C2 - 16612564

SN - 1023-3830

VL - 55

SP - 53

EP - 59

JO - Inflammation Research

JF - Inflammation Research

IS - 2

ER -

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this